ReviewCancer immunology, immunotherapy : CII2016

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.

Kinga Majchrzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.